Your browser doesn't support javascript.
loading
Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species.
Watson, Anna M D; Gould, Eleanor A M; Penfold, Sally A; Lambert, Gavin W; Pratama, Putra Riza; Dai, Aozhi; Gray, Stephen P; Head, Geoffrey A; Jandeleit-Dahm, Karin A.
  • Watson AMD; Department of Diabetes, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Gould EAM; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Penfold SA; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Lambert GW; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Pratama PR; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Dai A; Iverson Health Innovation Research Institute, Faculty of Health, Arts and Design, Swinburne University of Technology, Hawthorn, VIC, Australia.
  • Gray SP; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Head GA; Department of Diabetes, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Jandeleit-Dahm KA; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Front Physiol ; 10: 309, 2019.
Article en En | MEDLINE | ID: mdl-31040788
ABSTRACT
Patients with diabetic hypertensive nephropathy have accelerated disease progression. Diabetes and hypertension have both been associated with changes in renal catecholamines and reactive oxygen species. With a specific focus on renal catecholamines and oxidative stress we examined a combined model of hypertension and diabetes using normotensive BPN/3J and hypertensive BPH/2J Schlager mice. Induction of diabetes (5 × 55 mg/kg streptozotocin i.p.) did not change the hypertensive status of BPH/2J mice (telemetric 24 h avg. MAP, non-diabetic 131 ± 2 vs. diabetic 129 ± 1 mmHg, n.s at 9 weeks of study). Diabetes-associated albuminuria was higher in BPH/2J vs. diabetic BPN/3J (1205 + 196/-169 versus 496 + 67/-59 µg/24 h, p = 0.008). HPLC measurement of renal cortical norepinephrine and dopamine showed significantly greater levels in hypertensive mice whilst diabetes was associated with significantly lower catecholamine levels. Diabetic BPH/2J also had greater renal catecholamine levels than diabetic BPN/3J (diabetic norepinephrine BPN/3J 40 ± 4, BPH/2J 91 ± 5, p = 0.010; dopamine BPN/3J 2 ± 1; BPH/2J 3 ± 1 ng/mg total protein, p < 0.001 after 10 weeks of study). Diabetic BPH/2J showed greater cortical tubular immunostaining for monoamine oxidase A and cortical mitochondrial hydrogen peroxide formation was greater in both diabetic and non-diabetic BPH/2J. While cytosolic catalase activity was greater in non-diabetic BPH/2J it was significantly lower in diabetic BPH/2J (cytosolic BPH/2J 127 ± 12 vs. 63 ± 6 nmol/min/ml, p < 0.001). We conclude that greater levels of renal norepinephrine and dopamine associated with hypertension, together with diabetes-associated compromised anti-oxidant systems, contribute to increased renal oxidative stress in diabetes and hypertension. Elevations in renal cortical catecholamines and reactive oxygen species have important therapeutic implications for hypertensive diabetic patients.
Palabras clave